What does €5–10 million buy in European life sciences real estate?
France and Ireland lead the €5–10 million bracket, largely concentrated in point of care and R&D assets across Europe.
4 min read
Reverse conversions: when science facilities find new purpose
Converting former science facilities to new uses offers investors portfolio protection against tenant risk while unlocking new income streams.
3 min read
paid
London embraces high-rise labs
British Land seeks partners for Euston Tower conversion while One North Quay becomes Europe's tallest commercial laboratory building.
2 min read
paid
The global real estate leaders' playbook for European life sciences
Leading real estate investment managers have shown substantial interest in Europe's life sciences sector.
4 min read
paid
Why AI and proptech are essential for modern life sciences real estate
AI and property technology are transforming life sciences real estate, offering solutions for energy management, security and space utilisation whilst enhancing facility operations and research capabilities.
6 min read
paid
How funding drives headcount and demand for R&D space
Our analysis shows that every €1 billion in life sciences funding drives demand over time for c.17,000 square metres of R&D space
6 min read